![](/images/graphics-bg.png)
The Role of Autologous Dermal Micrografts in Regenerative Surgery: A Clinical Experimental Study
Joint Authors
Tresoldi, Marco Mario
Graziano, Antonio
Malovini, Alberto
Nicoletti, Giovanni
Faga, Angela
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-09-08
Country of Publication
Egypt
No. of Pages
8
Abstract EN
The aim of the study was the objective assessment of the effectiveness of a microfragmented dermal extract obtained with Rigenera™ technology in promoting the wound healing process in an in vivo homogeneous experimental human acute surgical wound model.
The study included 20 patients with 24 acute postsurgical soft tissue loss and a planned sequential two-stage repair with a dermal substitute and an autologous split-thickness skin graft.
Each acute postsurgical soft tissue loss was randomized to be treated either with an Integra® dermal substitute enriched with the autologous dermal micrografts obtained with Rigenera™ technology (group A—Rigenera™ protocol) or with an Integra® dermal substitute only (group B—control).
The reepithelialization rate in the wounds was assessed in both groups at 4 weeks through digital photography with the software “ImageJ.” The dermal cell suspension enrichment with the Rigenera™ technology was considered effective if the reepithelialized area was higher than 25% of the total wound surface as this threshold was considered far beyond the expected spontaneous reepithelialization rate.
In the Rigenera™ protocol group, the statistical analysis failed to demonstrate any significant difference vs.
the controls.
The old age of the patients likely influenced the outcome as the stem cell regenerative potential is reduced in the elderly.
A further explanation for the unsatisfying results of our trial might be the inadequate amount of dermal stem cells used to enrich the dermal substitutes.
In our study, we used a 1 : 200 donor/recipient site ratio to minimize donor site morbidity.
The gross dimensional disparity between the donor and recipient sites and the low concentration of dermal mesenchymal stromal stem cells might explain the poor epithelial proliferative boost observed in our study.
A potential option in the future might be preconditioning of the dermal stem cell harvest with senolytic active principles that would fully enhance their regenerative potential.
This trial is registered with trial protocol number NCT03912675.
American Psychological Association (APA)
Tresoldi, Marco Mario& Graziano, Antonio& Malovini, Alberto& Faga, Angela& Nicoletti, Giovanni. 2019. The Role of Autologous Dermal Micrografts in Regenerative Surgery: A Clinical Experimental Study. Stem Cells International،Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1210139
Modern Language Association (MLA)
Tresoldi, Marco Mario…[et al.]. The Role of Autologous Dermal Micrografts in Regenerative Surgery: A Clinical Experimental Study. Stem Cells International No. 2019 (2019), pp.1-8.
https://search.emarefa.net/detail/BIM-1210139
American Medical Association (AMA)
Tresoldi, Marco Mario& Graziano, Antonio& Malovini, Alberto& Faga, Angela& Nicoletti, Giovanni. The Role of Autologous Dermal Micrografts in Regenerative Surgery: A Clinical Experimental Study. Stem Cells International. 2019. Vol. 2019, no. 2019, pp.1-8.
https://search.emarefa.net/detail/BIM-1210139
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1210139